#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Management of dyslipidaemia in women


Authors: Šatný M.;  Vrablík M.
Authors place of work: Centrum preventivní kardiologie, III. interní klinika – klinika endokrinologie a metabolismu 1. LF UK a VFN v Praze
Published in the journal: Kardiol Rev Int Med 2019, 21(2): 73-77

Summary

There has been a marked decline in cardiovascular (CV) mortality in recent decades, but despite extensive preventive measures and new treatment modalities, these are the leading cause of death in developed countries, especially among women. It is known that dyslipidaemia is the most significant risk factor of atherosclerotic CV diseases for the female population, which typically occur together with dyslipidaemia during menopause. The key parameter of the lipid profile is LDL-cholesterol (independent of gender), but in some studies, a narrow association of CV risk with HDL-cholesterol or triglycerides is also found in women. According to the current guidelines for the management of dyslipidaemia there are no specific outputs for the female population; separate chapters are menopause, indication of oral contraceptives, hormonal replacement therapy or pregnancy. The guidelines explicitly mention a thorough CV risk assessment to avoid unnecessary initiation of treatment in low-risk patients. The LDL-cholesterol goals correspond to the CV risk categories; the basis of the treatment are statins, which can be combined with other lipid-lowering drugs as needed.

Keywords:

combination therapy – pregnancy – female population – diagnosis and treatment of dyslipidaemia – oral contraceptives – hormonal replacement therapy


Zdroje

1. Zemřelí 2017. Praha: ÚZIS ČR 2018.

2. Cífková R, Krajčoviechová A. Dyslipidemia and cardiovascular disease in women. Cur­rent cardiology reports 2015; 17(7): 609. doi: 10.1007/ s11886-015-0609-5.

3. Yusuf S, Hawken S, Ôunpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364(9438): 937–952. doi: 10.1016/ S0140-6736(04)17018-9.

4. Vaccarino V, Parsons L, Every NR et al. Sex-based differences in early mortality after myocardial infarction. N Eng J Med 1999; 341(4): 217–225. doi: 10.1056/ NEJM199907223410401.

5. Seshadri S, Beiser A, Kelly-Hayes M et al. The lifetime risk of stroke: estiamates from the Framingham Study. Stroke 2006; 37(2): 345–350. doi: 10.1161/ 01.STR.0000199613.38911.b2.

6. World Health Organization. The world health report 2002: Reducing risk, promoting healthy life. Geneva: World Health Organization 2002.

7. Jozífová M, Cífková R, Lánská V et al. Porovnání léčby hypertenze a rizikového profilu hypertoniků v obecné populaci a na specializovaném pracovišti. Cor Vasa 2003; 45(11): 533–541.

8. Feingold K, Brinot EA, Grunfeld C. The effect of endocrine disorders on lipids and lipoproteins. In: De Groot LJ, Chrousos G, Dungan K et al. (eds) Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000. Available at: https:/ / www.ncbi.nlm.nih.gov/ books/ NBK409608.

9. Šatný M, Vrablík M. Dyslipidemie u vybraných endokrinopatií. Kardiol Rev Int Med 2018; 20(3): 188–196.

10. Margolis K, Adami H, Lou J et al. A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women. Fertil Steril 2007; 88(2): 310–316. doi: 10.1016/ j.fertnstert.2006.11.
206.

11. Chakhtoura Z, Canonico M, Gompel A et al. Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis. J Clinl Endocrinol Metab 2011; 96(4): 1169–1174. doi: 10.1210/ jc.2010-2065.

12. Catapano AL, Graham I, De Backer G et al. 2016 ESC/ EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2016; 37(39): 2999–3058. doi: 10.1093/ eurheartj/ ehw272.

13. Bateman BT, Hernandez-Diaz S, Fischer MA
et al. Statins and congenital malformations: cohort study. BMJ 2015; 350: 1035. doi: 10.1136/ bmj.h1035.

14. Toth P, Phan BA. Dyslipidemia in women: etiology and management. Int J Womens Health 2014; 6: 185–194. doi: 10.2147/ IJWH.S38133.

Štítky
Paediatric cardiology Internal medicine Cardiac surgery Cardiology
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#